Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-1743.45%
operating margin TTM
-3.19%
revenue TTM
42.13 Million
revenue per share TTM
34.85$
valuation ratios | |
|---|---|
| pe ratio | -0.00 |
| peg ratio | 0.00 |
| price to book ratio | 1.68 |
| price to sales ratio | 0.02 |
| enterprise value multiple | -0.92 |
| price fair value | 1.68 |
profitability ratios | |
|---|---|
| gross profit margin | 98.75% |
| operating profit margin | -3.19% |
| pretax profit margin | -1058.25% |
| net profit margin | -1743.45% |
| return on assets | -110.4% |
| return on equity | -107557.27% |
| return on capital employed | -0.2% |
liquidity ratio | |
|---|---|
| current ratio | 2,966.35 |
| quick ratio | 2,966.35 |
| cash ratio | 1.93 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.08 |
| days of payables outstanding | 98.13 |
| cash conversion cycle | -98.04 |
| receivables turnover | 4,400.98 |
| payables turnover | 3.72 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.05 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.05 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -41,805.22 |
cash flow ratios | |
|---|---|
| free cash flow per share | -2,658.75 |
| cash per share | 1,209.63 |
| operating cash flow per share | -2,645.86 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -41,805.22 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -205.35 |
Frequently Asked Questions
When was the last time Lipella Pharmaceuticals Inc. (NASDAQ:LIPO) reported earnings?
Lipella Pharmaceuticals Inc. (LIPO) published its most recent earnings results on 14-11-2024.
What is Lipella Pharmaceuticals Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Lipella Pharmaceuticals Inc. (NASDAQ:LIPO)'s trailing twelve months ROE is -107557.27%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Lipella Pharmaceuticals Inc. (LIPO) currently has a ROA of -110.4%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did LIPO's net profit margin stand at?
LIPO reported a profit margin of -1743.45% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is LIPO's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2,966.35 in the most recent quarter. The quick ratio stood at 2,966.35, with a Debt/Eq ratio of 0.05.